Cargando…
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study
BACKGROUND: People with cancer are at increased risk of hospitalisation and death following infection with SARS-CoV-2. Therefore, we aimed to conduct one of the first evaluations of vaccine effectiveness against breakthrough SARS-CoV-2 infections in patients with cancer at a population level. METHOD...
Ejemplares similares
-
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study
por: Lee, Lennard Y.W., et al.
Publicado: (2022) -
Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review
por: Al Hajji, Youssra, et al.
Publicado: (2022) -
A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)
por: Starkey, Thomas, et al.
Publicado: (2023) -
As COVID-19 cases surge despite mass vaccination, it’s time to focus on the vulnerable
por: Little, Martin, et al.
Publicado: (2021) -
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research
por: Fittall, Matthew, et al.
Publicado: (2023)